Biogen

For decades, our scientists have been committed to understanding the complex biology of neurodegeneration. Our early research includes work to better understand Huntington’s disease (HD).    Through our collaboration with Aitia, we’re applying AI-enabled disease modeling to support biomarker discovery and translational research in HD, with the aim of informing future R&D strategies.    Read more about our ongoing work in neurology: ow.ly/caCo50YYrWM

May is Maternal Mental Health Awareness Month, a time to reflect on the importance of a mother’s mental health and the impact postpartum depression (PPD) can have. Too often, the signs and symptoms of PPD go unnoticed or are dismissed, leaving women to struggle in silence. Recognizing when something isn’t right and speaking with your doctor can be powerful first steps toward getting support. This month, we’re encouraging families, friends, and support systems to learn the potential signs of PPD and feel confident raising a flag when help may be needed. Explore resources and conversation starters: raisingyellowflags.com

This time each year, Friedreich Ataxia (FA) Awareness Month reminds us that time doesn’t slow down—and neither should progress. At Biogen, we’re turning urgency into progress for the FA community. Learn more about our work: ow.ly/Qs1s50YXIyz

Listening to the lupus community and working closely with advocacy groups like the Lupus Foundation of America, Inc. is essential for innovation. Hear more about the power of collaboration from Joy Buie, Ph.D., and discover how we’re working toward potential new treatment options for people living with different forms of lupus: ow.ly/nAWU50YUHTH #LupusAwarenessMonth | #WorldLupusDay

Thank you to Selena Gomez and the Lupus Research Alliance for shining a light on people living with Lupus, an often-unseen disease. #LupusAwarenessMonth

Biomarkers are helping reshape how diseases are detected, understood, and studied. Our teams are working to advance biomarker research to deepen our insights into disease biology and potentially enable earlier, more accurate detection. Discover more in our latest story: ow.ly/T95n50YV34X

The butterfly is a powerful symbol of lupus. During #LupusAwarenessMonth, we want to increase awareness to help better understand the disease and provide support for people living with the many types of lupus. Learn how we aim to advance treatment options: ow.ly/2j3n50YTCYs

The Biogen Foundation was honored to receive the Tim Russert Award for our philanthropic leadership and longstanding partnership with Boston Health Care for the Homeless Program (BHCHP). Biogen President and CEO Chris Viehbacher accepted the award.    We have been proud to partner with BHCHP to help keep the light on for our most vulnerable neighbors. Learn about one aspect of our partnership, a new approach to geriatric care for Boston’s unhoused population: ow.ly/iIJu50YTCJx #TeamBiogen

Brain changes linked to Alzheimer’s disease can begin 20 years or more before memory loss and other symptoms develop, according to the 2026 Alzheimer’s Disease Facts and Figures report from the Alzheimer's Association®. This underscores the critical importance of early detection and timely intervention.    At Biogen, we are deeply committed to working alongside the Alzheimer’s community to help advance innovation across the continuum, including efforts to better understand the disease and intervene earlier, before symptoms appear, to support people living with this progressive and relentless disease and their caregivers.

We were honored to share the latest clinical research updates on our Friedreich ataxia (FA) pipeline during the Friedreich's Ataxia Research Alliance (FARA) FA Research Reception in Torrance, California.     Events like these reinforce the importance of our efforts to help advance innovation to make a lasting impact for the FA community. Learn more about our work: ow.ly/KjBr50YTsev